Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Paula M. B. Pahl"'
Publikováno v:
Journal of Cardiovascular Pharmacology. 45:539-544
Endothelial cell (EC) and vascular smooth muscle cell (VSMC) interactions play critical roles in restenosis following vascular injury. We examined the effects of intracellular iron chelation on endothelial cell cycle progression and VSMC modulation o
Autor:
Lawrence D. Horwitz, Paula M. B. Pahl
Publikováno v:
Cancer Investigation. 23:683-691
Iron is an essential micronutrient for the growth and function of all cells. It is, therefore, an attractive target for chemotherapeutic compounds. Numerous studies in vitro and in vivo provide evidence that iron chelators may be effective antitumor
Publikováno v:
American Journal of Respiratory Cell and Molecular Biology. 25:226-232
Peroxiredoxin (Prx) is an important antioxidant defense enzyme that reduces hydrogen peroxide to molecular oxygen by using reducing equivalents from thioredoxin. We report that lung Prx I messenger RNA (mRNA) is specifically upregulated by oxygen. Th
Autor:
Yvonne K. Hodges, Paula M. B. Pahl, Eli A. Rosenthal, Xiang-Dong Yan, Lawrence D. Horwitz, Marcus A. Horwitz
Publikováno v:
Journal of Biological Chemistry. 275:17821-17826
Proliferation of vascular smooth muscle cells (VSMC) is characteristic of restenosis following balloon angioplasty. We show here that a low concentration of a novel iron chelator, desferri-exochelin 772SM, reversibly arrests the growth of human VSMC
Publikováno v:
Journal of experimental therapeuticsoncology. 6(3)
The lipid-soluble iron chelator desferri-exochelin (D-Exo) causes reversible cell cycle arrest in normal human mammary epithelial cells (NHMEC) but triggers apoptotic cell death in human breast cancer cells. We studied the effects of iron chelation w
Autor:
Kathryn B. Horwitz, Paula M. B. Pahl, M. B. Perryman, Yvonne K. Hodges, L. Meltesen, Lawrence D. Horwitz
Publikováno v:
Genomics. 53:410-412
Publikováno v:
Breast cancer research and treatment. 69(1)
A major goal of cancer chemotherapy is the identification of cytotoxic compounds that are highly selective for cancer cells. We describe here one such compound – a novel iron chelator, desferri-exochelin 772SM. This desferri-exochelin has unique ch